Kiniksa Pharmaceuticals International, plc Deferred Tax Assets, Goodwill and Intangible Assets
Kiniksa Pharmaceuticals International, plc (KNSA) had Deferred Tax Assets, Goodwill and Intangible Assets of $733.22 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-02-24
- 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $733.22M.
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $773.69M.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $215.40M.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $181.46M.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2025-12-31 | $733.22M 10-K · filed 2026-02-24 |
| 2024-12-31 | $773.69M 10-K · filed 2026-02-24 |
| 2023-12-31 | $215.40M 10-K · filed 2025-02-25 |
| 2022-12-31 | $181.46M 10-K · filed 2024-02-28 |
| 2021-12-31 | $107.04M 10-K · filed 2023-03-02 |